Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7XUD

Structure of G9a in complex with compound 26a

Summary for 7XUD
Entry DOI10.2210/pdb7xud/pdb
DescriptorHistone-lysine N-methyltransferase EHMT2, ZINC ION, CHLORIDE ION, ... (8 entities in total)
Functional Keywordshistone lysine methyltransferase, inhibitor, protein-inhibitor complex, transferase
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight67682.76
Authors
Niwa, H.,Shirai, F.,Sato, S.,Nishigaya, Y.,Umehara, T. (deposition date: 2022-05-18, release date: 2023-03-29, Last modification date: 2023-11-29)
Primary citationNishigaya, Y.,Takase, S.,Sumiya, T.,Kikuzato, K.,Sato, T.,Niwa, H.,Sato, S.,Nakata, A.,Sonoda, T.,Hashimoto, N.,Namie, R.,Honma, T.,Umehara, T.,Shirouzu, M.,Koyama, H.,Yoshida, M.,Ito, A.,Shirai, F.
Discovery of Novel Substrate-Competitive Lysine Methyltransferase G9a Inhibitors as Anticancer Agents.
J.Med.Chem., 66:4059-4085, 2023
Cited by
PubMed Abstract: Identification of structurally novel inhibitors of lysine methyltransferase G9a has been a subject of intense research in cancer epigenetics. Starting with the high-throughput screening (HTS) hit - obtained from the chemical library of the University of Tokyo Drug Discovery Initiative, the structure-activity relationship of the unique substrate-competitive inhibitors was established with the help of X-ray crystallography and fragment molecular orbital (FMO) calculations for the ligand-protein interaction. Further optimization of the characteristics and drug metabolism and pharmacokinetics (DMPK) properties led to the identification of (RK-701), which is a structurally distinct potent inhibitor of G9a/GLP (IC = 27/53 nM). Compound exhibited remarkable selectivity against other related methyltransferases, dose-dependent attenuation of cellular H3K9me2 levels, and tumor growth inhibition in MOLT-4 cells . Moreover, compound showed inhibition of tumor initiation and growth in a carcinogen-induced hepatocellular carcinoma (HCC) mouse model without overt acute toxicity.
PubMed: 36882960
DOI: 10.1021/acs.jmedchem.2c02059
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.45 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon